Cytogenetic and Molecular Tumor Profiling for Type 1 and Type 2 Papillary Renal Cell Carcinoma
暂无分享,去创建一个
Amnon Zisman | David B Seligson | A. Belldegrun | N. Rao | B. Shuch | D. Seligson | A. Zisman | A. Pantuck | T. Klatte | F. Kabbinavar | J. Said | Allan J Pantuck | Arie S Belldegrun | Jonathan W Said | Tobias Klatte | Brian Shuch | Nagesh P Rao | Fairooz F Kabbinavar | Jeffrey C LaRochelle | J. Larochelle
[1] B. Delahunt,et al. Nucleolar Grade But Not Fuhrman Grade is Applicable to Papillary Renal Cell Carcinoma , 2006, The American journal of surgical pathology.
[2] J. Cheville,et al. Long-term survival of patients with unilateral sporadic multifocal renal cell carcinoma according to histologic subtype compared with patients with solitary tumors after radical nephrectomy. , 2004, Urology.
[3] N. Rioux-Leclercq,et al. Prognostic value of histologic subtypes in renal cell carcinoma: a multicenter experience. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[4] Francesco Pagano,et al. Duplication and overexpression of the mutant allele of the MET proto-oncogene in multiple hereditary papillary renal cell tumours , 1998, Oncogene.
[5] L. Aaltonen,et al. Inherited susceptibility to uterine leiomyomas and renal cell cancer , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[6] W. Linehan,et al. Novel mutations of the MET proto-oncogene in papillary renal carcinomas , 1999, Oncogene.
[7] J. Kononen,et al. Tissue microarrays for high-throughput molecular profiling of tumor specimens , 1998, Nature Medicine.
[8] Bin Tean Teh,et al. A molecular classification of papillary renal cell carcinoma. , 2005, Cancer research.
[9] J. Cheville,et al. The effect of bilaterality, pathological features and surgical outcome in nonhereditary renal cell carcinoma. , 2003, The Journal of urology.
[10] H. Kanetake,et al. Presence of Phosphorylated Hepatocyte Growth Factor Receptor/c-Met Is Associated with Tumor Progression and Survival in Patients with Conventional Renal Cell Carcinoma , 2006, Clinical Cancer Research.
[11] C. Compton,et al. AJCC Cancer Staging Manual , 2002, Springer New York.
[12] Y. Chrétien,et al. Prognostic factors for the survival of patients with papillary renal cell carcinoma: meaning of histological typing and multifocality. , 2003, The Journal of urology.
[13] P. Choyke,et al. Two North American families with hereditary papillary renal carcinoma and identical novel mutations in the MET proto-oncogene. , 1998, Cancer research.
[14] R. Figlin,et al. The Advanced Renal Cell Carcinoma Sorafenib (ARCCS) expanded access trial: Safety and efficacy in patients (pts) with non-clear cell (NCC) renal cell carcinoma (RCC) , 2007 .
[15] M. Copin,et al. Morphologic Subtyping of Papillary Renal Cell Carcinoma: Correlation with Prognosis and Differential Expression of MUC1 between the Two Subtypes , 2002, Modern Pathology.
[16] P. Choyke,et al. Identification of the Genes for Kidney Cancer: Opportunity for Disease-Specific Targeted Therapeutics , 2007, Clinical Cancer Research.
[17] G. Jakse,et al. Cytogenetic and morphologic typing of 58 papillary renal cell carcinomas: evidence for a cytogenetic evolution of type 2 from type 1 tumors. , 2003, Cancer research.
[18] A. Paetau,et al. Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer , 2002, Nature Genetics.
[19] J. Cheville,et al. Histologic coagulative tumor necrosis as a prognostic indicator of renal cell carcinoma aggressiveness , 2005, Cancer.
[20] Iscn. International System for Human Cytogenetic Nomenclature , 1978 .
[21] Kazuki Kobayashi,et al. VHL tumor suppressor gene alterations associated with good prognosis in sporadic clear-cell renal carcinoma. , 2002, Journal of the National Cancer Institute.
[22] C. Elie,et al. Survival analysis of 130 patients with papillary renal cell carcinoma: prognostic utility of type 1 and type 2 subclassification. , 2007, Urology.
[23] J. Cheville,et al. Comparisons of Outcome and Prognostic Features Among Histologic Subtypes of Renal Cell Carcinoma , 2003, The American journal of surgical pathology.
[24] H. Aburatani,et al. Papillary Renal Cell Carcinoma: Quantitation of Chromosomes 7 and 17 by FISH, Analysis of Chromosome 3p for LOH, and DNA Ploidy , 1996, Diagnostic molecular pathology : the American journal of surgical pathology, part B.
[25] G. Kovacs,et al. Cytogenetics of papillary renal cell tumors , 1991, Genes, chromosomes & cancer.
[26] B. Delahunt,et al. Papillary renal cell carcinoma: a clinicopathologic and immunohistochemical study of 105 tumors. , 1997, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.
[27] H. Moch,et al. Chromosomal imbalances in papillary renal cell carcinoma: genetic differences between histological subtypes. , 1998, The American journal of pathology.
[28] Holger Moch,et al. The Heidelberg classification of renal cell tumours , 1997, The Journal of pathology.
[29] B. Delahunt,et al. Morphologic typing of papillary renal cell carcinoma: comparison of growth kinetics and patient survival in 66 cases. , 2001, Human pathology.
[30] S. Horvath,et al. Epithelial Cell Adhesion Molecule (KSA) Expression , 2004, Clinical Cancer Research.
[31] E. McFadden,et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group , 1982, American journal of clinical oncology.
[32] W. Marston Linehan,et al. Trisomy 7-harbouring non-random duplication of the mutant MET allele in hereditary papillary renal carcinomas , 1998, Nature Genetics.
[33] M. Sanders,et al. Unique patterns of allelic imbalance distinguish type 1 from type 2 sporadic papillary renal cell carcinoma. , 2002, The American journal of pathology.
[34] S. Horvath,et al. Correlation of Ki-67 and gelsolin expression to clinical outcome in renal clear cell carcinoma. , 2003, Urology.
[35] P. Comoglio,et al. Overexpression of the met/HGF receptor in renal cell carcinomas , 1996, International journal of cancer.
[36] G. Kovacs. Papillary renal cell carcinoma. A morphologic and cytogenetic study of 11 cases. , 1989, The American journal of pathology.